Sign Up

MANK

COM:MANKINDPHARMA

Mankind Pharma

  • Stock

Last Close

2,714.25

06/11 05:20

Market Cap

848.24B

Beta: -

Volume Today

1.01M

Avg: -

OverviewAnalysisFinancialsFilingspeopleAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '22
Jun '22
Sep '22
Dec '22
Mar '23
Jun '23
Sep '23
Dec '23
Mar '24
Jun '24
net income
2.63B
-
2.93B
11.22%
4.20B
43.46%
3.79B
9.70%
2.85B
24.68%
4.87B
70.57%
5.01B
2.91%
4.54B
9.43%
4.71B
3.85%
5.36B
13.85%
depreciation and amortization
473.58M
-
847.91M
-
845.21M
0.32%
873.55M
3.35%
964.85M
10.45%
1.10B
13.72%
deferred income tax
stock based compensation
change in working capital
-4.44B
-
2.58B
-
accounts receivables
inventory
-3.42B
-
-198.74M
-
accounts payables
other working capital
-1.02B
-
2.77B
-
other non cash items
-1.05B
-
-2.93B
177.54%
-4.20B
43.46%
-1.10B
73.74%
-2.01B
82.29%
-4.00B
98.85%
-4.05B
1.26%
-3.44B
14.96%
-4.71B
36.97%
-5.36B
13.85%
net cash provided by operating activities
-2.39B
-
6.11B
-
1.69B
72.34%
1.75B
3.35%
1.93B
10.45%
2.19B
13.72%
investments in property plant and equipment
-19.48B
-
-2.22B
-
acquisitions net
-1.88M
-
-68.54M
-
purchases of investments
-1.75B
-
1.64B
-
sales maturities of investments
16.54B
-
-1.91B
-
other investing activites
1.35B
-
134.03M
-
net cash used for investing activites
-3.34B
-
-2.42B
-
debt repayment
-1.92B
-
-7.16B
-
common stock issued
common stock repurchased
dividends paid
other financing activites
7.74B
-
3.79B
-
net cash used provided by financing activities
5.82B
-
-3.38B
-
effect of forex changes on cash
-210K
-
39.87M
-
net change in cash
94.35M
-
358.97M
-
1.69B
370.91%
1.75B
3.35%
1.93B
10.45%
2.19B
13.72%
cash at beginning of period
2.74B
-
2.83B
3.45%
2.58B
-
1.36B
47.28%
3.05B
124.50%
605.18M
80.15%
2.53B
318.86%
cash at end of period
2.83B
-
2.83B
0.00%
2.93B
-
3.05B
3.88%
4.80B
57.32%
2.53B
47.14%
4.73B
86.57%
operating cash flow
-2.39B
-
6.11B
-
1.69B
72.34%
1.75B
3.35%
1.93B
10.45%
2.19B
13.72%
capital expenditure
-19.48B
-
-2.22B
-
free cash flow
-21.87B
-
3.90B
-
1.69B
56.60%
1.75B
3.35%
1.93B
10.45%
2.19B
13.72%

All numbers in (except ratios and percentages)